AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 36 filers reported holding AQUESTIVE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.02 and the average weighting 2.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $15 | -100.0% | 12,884 | -87.9% | 0.00% | -66.7% |
Q2 2022 | $68,000 | +142.9% | 106,408 | +893.1% | 0.01% | +200.0% |
Q1 2022 | $28,000 | -90.9% | 10,715 | -86.5% | 0.00% | -93.8% |
Q4 2021 | $308,000 | +316.2% | 79,138 | +327.3% | 0.03% | +357.1% |
Q2 2021 | $74,000 | -76.6% | 18,521 | -68.6% | 0.01% | -79.4% |
Q4 2020 | $316,000 | -44.5% | 59,050 | -49.6% | 0.03% | -65.3% |
Q3 2020 | $569,000 | +973.6% | 117,206 | +972.0% | 0.10% | +1533.3% |
Q2 2020 | $53,000 | – | 10,933 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bratton Capital Management, L.P. | 9,810,958 | $16,188,081 | 100.00% |
Vahanian & Associates Financial Planning Inc. | 725,208 | $1,196,593 | 3.78% |
Bracebridge Capital, LLC | 428,571 | $707,142 | 0.39% |
Latash Investments, LLC | 243,134 | $401,171 | 0.32% |
XTX Topco Ltd | 138,145 | $227,939 | 0.04% |
ARMISTICE CAPITAL, LLC | 1,158,000 | $1,910,700 | 0.03% |
OCCUDO QUANTITATIVE STRATEGIES LP | 84,355 | $139,186 | 0.01% |
Hillsdale Investment Management Inc. | 66,600 | $109,890 | 0.01% |
D.B. Root & Company, LLC | 12,950 | $21,368 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 147,856 | $243,962 | 0.01% |